Alzheimer's Disease is becoming an increasingly significant public health issue in the Asia-Pacific region due to its rapidly aging population. The prevalence of Alzheimer's and other forms of dementia is growing, presenting complex challenges for healthcare systems, caregivers, and governments.
Alzheimer’s disease is often categorized into four stages, each with distinct symptoms and progression. Preclinical (No Symptoms Yet), Mild Alzheimer’s (Early-Stage), Moderate Alzheimer’s (Middle-Stage) and lastly Severe Alzheimer’s (Late-Stage).
Key Statistics and Facts:
- Prevalence: The Asia-Pacific region is home to about 60% of the world’s population, and its elderly population is expanding quickly. In 2020, the number of people living with dementia in the region was estimated at around 23 million, a figure expected to nearly triple to over 70 million by 2050. Alzheimer's disease accounts for 60–70% of dementia cases in the region.
- Country-specific Data: China: As the world’s most populous country, China has one of the highest numbers of Alzheimer's patients. In 2020, an estimated 9.83 million people in China were living with dementia, and this number is projected to increase sharply. Japan: Japan has one of the oldest populations in the world, with over 28% aged 65 or older. Currently, about 5 million people in Japan are living with dementia, with Alzheimer’s being the most common cause. Australia: In 2020, approximately 472,000 Australians were living with dementia, with Alzheimer’s being the leading cause. This number is expected to exceed 1 million by 2058.
- Economic Impact: The cost of dementia, including Alzheimer's disease, is significant for the Asia-Pacific region. In 2015, the global cost of dementia was estimated at US$818 billion, with Asia-Pacific bearing a large share of that cost. By 2030, this is projected to rise to over $2 trillion worldwide, driven largely by the increasing burden in Asia-Pacific.
- Risk Factors: The risk factors for Alzheimer's in the Asia-Pacific region include an aging population, lifestyle factors such as increasing urbanization, and rising rates of diabetes, hypertension, and obesity. There are also concerns about underdiagnosis in low and middle income countries due to limited awareness and inadequate healthcare infrastructure.
- Healthcare and Support Challenges: Many countries in the region are unprepared for the rising tide of Alzheimer's and other dementias. There is a shortage of trained healthcare professionals, insufficient specialized care facilities, and limited public awareness. Additionally, caregiving is often done informally by family members, adding financial and emotional stress and burden on families.
Governments and organizations across the Asia-Pacific region are starting to implement dementia action plans. For example:
- Japan has introduced comprehensive care plans and dementia-friendly communities.
- Australia is investing in research, early diagnosis, and support services through its National Dementia Action Plan.
- China is expanding its healthcare system to accommodate the growing needs of its aging population, though gaps still remain in rural areas.
Alzheimer's disease in the Asia-Pacific region is a growing concern, with millions expected to be affected in the coming decades. The region faces unique challenges due to its diverse healthcare systems, varying economic conditions, and cultural attitudes toward aging and dementia care. Effective public health strategies and increased investment in dementia care infrastructure are critical to managing this rising health crisis.
Vista Health is currently supporting the development of whitepapers to advocate the need to advance post stroke care to prevent the rise in Alzheimer’s in Singapore.?
For more information on how Vista Health can help you today, kindly visit our website or email us at [email protected]
